Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Pathology visible "post mortem" includes neurodegeneration and extracellular deposition of amyloids, both in neuritic plaques and diffuse deposits. [1] The major proteinaceous component of AD amyloids is the amyloid-b protein (Ab)
Active Transport of Amino Acids by a Guanidiniocarbonyl–Pyrrole Receptor
✍ Scribed by Christian Urban; Carsten Schmuck
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 436 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0947-6539
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Glycine, an important inhibitory neurotransmitter in the mammalian central nervous system (CNS), has been shown to modulate peripheral immune cell responses. In that respect, glycine levels are increased in several neuroinflammatory disorders, such as amyotrophic lateral sclerosis (ALS)
## Abstract Racemic protonated amino acid methyl esters were efficiently transported through a dichloromethane phase using L,L‐Cbz‐bis(15‐crown‐5)DOPA‐OMe as a carrier. The enantioselectivity was however marginal. The (15‐crown‐5) rings of the carrier were essential for affinity, as Cbz‐bis(12‐crow
A cDNA clone named L21 was isolated from L6 rat muscle cells by complementation of a yeast proline transport mutant. L21 cDNA has 2,268 bp and codes for a peptide of 228 amino acids with four potential transmembrane domains. The amino acid sequence of L21 shows no homology to any known proteins. Exp